Bangkok, Thailand — July 02, 2026 — CPhI South East Asia 2026 is projected to host over 10,000 attendees and 400+ exhibiting companies from more than 70 countries, marking a significant expansion for the region's pharmaceutical trade event. The event will open on July 08, 2026, at the Queen Sirikit National Convention Center (QSNCC) in Bangkok, Thailand, located at 60 Queen Sirikit National Convention Center, Ratchadaphisek Road, Khlong Toei District, Bangkok 10110.
Event Scale and Regional Impact
Organized annually by Informa Markets, CPhI South East Asia serves as a pharmaceutical solutions event aimed at promoting the pharmaceutical industry across South East Asia. The 2026 edition anticipates surpassing previous attendance figures. In 2023, the event welcomed 8,258 visitors and featured 390 exhibitors. The 2022 edition attracted 7,662 pharma industry professionals from 44 countries, with 199 exhibiting companies representing 23 countries. This growth underscores the increasing engagement with Southeast Asia's pharmaceutical markets.
Key Sectors and Clinical Relevance
The exhibition will feature core sectors critical to pharmaceutical development and patient care. These include Active Pharmaceutical Ingredients (API), Biopharma & generic drugs, Drug delivery systems, Finished dosage formulations, and Cold chain & logistics. The focus on these areas is pertinent for addressing challenges in drug manufacturing, ensuring product stability, and facilitating efficient distribution, which directly impacts patient access and treatment outcomes. Other significant exhibit sectors will cover Animal health, Excipients, Herbal medicines, and Natural extracts, reflecting the diverse scope of pharmaceutical applications. Furthermore, Analytical & lab equipment, Pharmaceutical machinery & technology, and Packaging & labelling will support advancements in research, production quality control, and product integrity, all essential for regulatory compliance and patient safety.
Engagement Platforms and Regulatory Dialogue
CPhI South East Asia will target professionals across the entire pharmaceutical supply chain, including raw material and API suppliers, packaging specialists, and finished product manufacturers. The event will also engage regional and global pharma manufacturers, distributors, contract manufacturers, and companies interested in bio-investment and biosimilar production. Concurrent programs are designed to foster knowledge exchange and industry interaction. These include Conferences and technical seminars, the Innovation stage, Pharma markets hub, and PharmaQuest (a quiz competition). For 2026, new additions will feature the Match & Meet Lounge, a Cleanroom Showcase, and a Natural Extract Zone. Country Pavilions from China, India, Indonesia, Malaysia, South Korea, Taiwan, Thailand, and Vietnam will also be present, facilitating international collaboration and market understanding. The 2025 edition included an Innovation Showcase, indicating a continuous focus on emerging technologies. Exhibitors will have opportunities for networking and exploring market trends, with business matching services available to schedule meetings with potential partners and key industry players prior to the event.
For further details regarding the event schedule, registration, or exhibitor information, interested parties may visit the official website at https://www.cphi.com/sea/en/home.html.